Cargando…
Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk
As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling pathways, such as nuclear factor-κB (NF-κB), Wnt, and mitogen-activated protein (MAP)/phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (m...
Autores principales: | Barzaman, Khadijeh, Vafaei, Rana, Samadi, Mitra, Kazemi, Mohammad Hossein, Hosseinzadeh, Aysooda, Merikhian, Parnaz, Moradi-Kalbolandi, Shima, Eisavand, Mohammad Reza, Dinvari, Houra, Farahmand, Leila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389806/ https://www.ncbi.nlm.nih.gov/pubmed/35986321 http://dx.doi.org/10.1186/s12935-022-02658-z |
Ejemplares similares
-
MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
por: Hosseinzadeh, Aysooda, et al.
Publicado: (2022) -
Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study
por: Vafaei, Rana, et al.
Publicado: (2022) -
Triple-negative breast cancer: understanding Wnt signaling in drug resistance
por: Merikhian, Parnaz, et al.
Publicado: (2021) -
Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling
por: Khodabakhsh, Farnaz, et al.
Publicado: (2021) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015)